EE459 Early Intensification of Oral Semaglutide in the UK: A Cost-Effectiveness Analysis Versus Continuing Metformin and SGLT-2 Inhibitor Therapy
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.704
https://www.valueinhealthjournal.com/article/S1098-3015(22)02908-4/fulltext
Title :
EE459 Early Intensification of Oral Semaglutide in the UK: A Cost-Effectiveness Analysis Versus Continuing Metformin and SGLT-2 Inhibitor Therapy
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02908-4&doi=10.1016/j.jval.2022.09.704
First page :
Section Title :
Open access? :
No
Section Order :
10241